Skip to main content

NGM Biopharmaceuticals Inc

NGMDelisted Apr 5, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001426332

NGM Biopharmaceuticals Inc was delisted on Apr 5, 2024; its insiders filed their last Form 4 on Apr 8, 2024; 75 institutions reported holding it in 13F filings for Q1 2024, worth $55.1M in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by NGM Biopharmaceuticals Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for NGM Biopharmaceuticals Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for NGM Biopharmaceuticals Inc
NameTitleLast reported holdingLast filingFilings, past year
Column Group GP, LP10% Owner1,000IndirectApr 8, 20240
Column Group III-A, LP10% Owner1,000IndirectApr 8, 20240
Column Group III, LP10% Owner1,000IndirectApr 8, 20240
Column Group III GP, LP10% Owner1,000IndirectApr 8, 20240
Column Group IV-A, LP10% Owner1,000IndirectApr 8, 20240
Column Group IV, LP10% Owner1,000IndirectApr 8, 20240
Column Group IV GP, LP10% Owner1,000IndirectApr 8, 20240
TCG IV GP, LLC10% Owner1,000IndirectApr 8, 20240
Column Group Opportunity III, LP10% Owner1,000IndirectApr 8, 20240
Column Group Opportunity III GP, LP10% Owner1,000IndirectApr 8, 20240
Column Group L PDirector, 10% Owner1,000IndirectApr 8, 20240
Column Group II, LP10% Owner1,000IndirectApr 8, 20240
Svennilson Peter10% Owner1,000IndirectApr 8, 20240
Kutzkey Tim10% Owner1,000IndirectApr 8, 20240
Column Group II GP, LP10% Owner1,000IndirectApr 8, 20240
Column Group Management LP10% Owner1,000IndirectApr 8, 20240
Ponoi Capital, LP10% Owner1,000IndirectApr 8, 20240
Ponoi Management, LLC10% Owner1,000IndirectApr 8, 20240
Ponoi Capital II, LP10% Owner1,000IndirectApr 8, 20240
Ponoi II Management, LLC10% Owner1,000IndirectApr 8, 20240
Goeddel David VDirector, 10% Owner1,000IndirectApr 8, 20240
Rieflin William JLDirector0IndirectApr 8, 20240
Perlmutter Roger MDirector–Apr 8, 20240
Pierce Valerie LSee Remarks0Apr 8, 20240
Viret Jean-FredericChief Financial Officer0Apr 8, 20240
Lieu Hsiao DChief Medical Officer0Apr 8, 20240
Hooper Suzanne SawochkaDirector0Apr 8, 20240
Guyer Shelly DDirector–Apr 8, 20240
Woodhouse David JChief Executive Officer0IndirectApr 8, 20240
Ho CaroleDirector–Apr 8, 20240
TCG Opportunity III GP, LLC10% Owner1,000IndirectApr 8, 20240
Perlich IrenePrincipal Accounting Officer0Apr 8, 20240
Chen Jin-LongChief Scientific Officer972,893Mar 6, 20230
Nolan Mangini SiobhanPresident and CFO76,000Mar 6, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 13, 2022 (view filing)Jun 94 daysGoeddel David VDirector, 10% OwnerPPurchase+984.2K$13.50+$13.3MNew position90.4K after2 lots
Jun 6, 2022 (view filing)4:44 PM ETJun 24 daysColumn Group L P and 7 othersDirector, 10% OwnerPPurchase+34.2K$13.03+$445.7K+143.9%58.0K after2 lotsDuplicate filing
Jun 6, 2022 (view filing)4:43 PM ETJun 24 daysColumn Group L P and 9 othersDirector, 10% OwnerPPurchase+34.2K$13.03+$445.7K+143.9%58.0K after2 lots
Jun 6, 2022 (view filing)Jun 24 daysGoeddel David VDirector, 10% OwnerPPurchase+34.2K$13.03+$445.6K+143.9%58.0K after2 lots
Jun 2, 2022 (view filing)4:28 PM ETMay 31-Jun 12 daysColumn Group L P and 7 othersDirector, 10% OwnerPPurchase+153.8K$13.46+$2.07MNew position56.8K after4 lotsDuplicate filing
Jun 2, 2022 (view filing)4:26 PM ETMay 31-Jun 12 daysColumn Group L P and 9 othersDirector, 10% OwnerPPurchase+153.8K$13.46+$2.07MNew position56.8K after4 lots
Jun 2, 2022 (view filing)May 31-Jun 12 daysGoeddel David VDirector, 10% OwnerPPurchase+153.8K$13.46+$2.07MNew position56.8K after4 lots
May 31, 2022 (view filing)5:02 PM ETMay 26-275 daysColumn Group L P and 7 othersDirector, 10% OwnerPPurchase+22.9K$13.49+$309.0K+79.4%51.8K after4 lotsDuplicate filing
May 31, 2022 (view filing)4:59 PM ETMay 26-275 daysColumn Group L P and 9 othersDirector, 10% OwnerPPurchase+22.9K$13.49+$309.0K+79.4%51.8K after4 lots
May 31, 2022 (view filing)May 26-275 daysGoeddel David VDirector, 10% OwnerPPurchase+22.9K$13.49+$309.0K+79.4%51.8K after4 lots
May 26, 2022 (view filing)4:13 PM ETMay 24-252 daysColumn Group L P and 7 othersDirector, 10% OwnerPPurchase+61.1K$13.42+$819.9KNew position51.0K after4 lotsDuplicate filing
May 26, 2022 (view filing)4:11 PM ETMay 24-252 daysColumn Group L P and 9 othersDirector, 10% OwnerPPurchase+61.1K$13.42+$819.9KNew position51.0K after4 lots
May 26, 2022 (view filing)May 24-252 daysGoeddel David VDirector, 10% OwnerPPurchase+61.1K$13.41+$819.8KNew position51.0K after4 lots
May 23, 2022 (view filing)4:14 PM ETMay 19-204 daysColumn Group L P and 7 othersDirector, 10% OwnerPPurchase+39.7K$13.36+$530.5K+427.5%49.0K after4 lotsDuplicate filing
May 23, 2022 (view filing)4:12 PM ETMay 19-204 daysColumn Group L P and 9 othersDirector, 10% OwnerPPurchase+39.7K$13.36+$530.5K+427.5%49.0K after4 lots
May 23, 2022 (view filing)May 19-204 daysGoeddel David VDirector, 10% OwnerPPurchase+39.7K$13.36+$530.4K+427.5%49.0K after4 lots
May 19, 2022 (view filing)4:39 PM ETMay 17-182 daysColumn Group L P and 7 othersDirector, 10% OwnerPPurchase+151.7K$13.33+$2.02MNew position47.7K after4 lotsDuplicate filing
May 19, 2022 (view filing)4:35 PM ETMay 17-182 daysColumn Group L P and 9 othersDirector, 10% OwnerPPurchase+151.7K$13.33+$2.02MNew position47.7K after4 lots
May 19, 2022 (view filing)May 17-182 daysGoeddel David VDirector, 10% OwnerPPurchase+151.7K$13.33+$2.02MNew position47.7K after4 lots
May 17, 2022 (view filing)4:22 PM ETMay 13-164 daysColumn Group L P and 7 othersDirector, 10% OwnerPPurchase+162.5K$12.90+$427.9KNew position42.7K after4 lotsDuplicate filing
May 17, 2022 (view filing)4:21 PM ETMay 13-164 daysColumn Group L P and 9 othersDirector, 10% OwnerPPurchase+162.5K$12.90+$427.9KNew position42.7K after4 lots
May 17, 2022 (view filing)May 13-164 daysGoeddel David VDirector, 10% OwnerPPurchase+162.5K$12.90+$427.8KNew position42.7K after4 lots
May 13, 2022 (view filing)5:32 PM ETMay 11-122 daysColumn Group L P and 7 othersDirector, 10% OwnerPPurchase+166.3K$11.43+$1.90MNew position37.3K after8 lotsDuplicate filing
May 13, 2022 (view filing)5:30 PM ETMay 11-122 daysColumn Group L P and 9 othersDirector, 10% OwnerPPurchase+166.3K$11.43+$1.90MNew position37.3K after8 lots
May 13, 2022 (view filing)May 11-122 daysGoeddel David VDirector, 10% OwnerPPurchase+166.3K$11.44+$1.90MNew position37.3K after8 lots
May 11, 2022 (view filing)6:14 PM ETMay 9-102 daysColumn Group L P and 7 othersDirector, 10% OwnerPPurchase+114.4K$10.95+$1.25MNew position31.8K after4 lotsDuplicate filing
May 11, 2022 (view filing)6:03 PM ETMay 9-102 daysColumn Group L P and 9 othersDirector, 10% OwnerPPurchase+114.4K$10.95+$1.25MNew position31.8K after4 lots
May 11, 2022 (view filing)May 9-102 daysGoeddel David VDirector, 10% OwnerPPurchase+114.4K$10.95+$1.25MNew position31.8K after4 lots
Jan 26, 2022 (view filing)7:14 PM ETJan 24-252 daysColumn Group L P and 7 othersDirector, 10% OwnerPPurchase+849.7K––New position28.0K after4 lotsDuplicate filing
Jan 26, 2022 (view filing)7:12 PM ETJan 24-252 daysColumn Group L P and 9 othersDirector, 10% OwnerPPurchase+849.7K––New position28.0K after4 lotsDuplicate filing
Jan 26, 2022 (view filing)Jan 24-252 daysGoeddel David VDirector, 10% OwnerPPurchase+849.7K––New position28.0K after4 lots
Dec 7, 2021 (view filing)Dec 6-71 dayChen Jin-LongChief Scientific OfficerSSale−30.0K$18.41−$552.1K−3.2%908.9K after2 lots
Nov 19, 2021 (view filing)Nov 181 dayWoodhouse David JChief Executive OfficerSSale−15.0K$20.02−$300.3K−100.0%0 after
Nov 16, 2021 (view filing)Nov 151 dayChen Jin-LongChief Scientific OfficerSSale−30.0K$19.73−$591.8K−3.3%869.4K after2 lots
Oct 13, 2021 (view filing)Oct 11-122 daysChen Jin-LongChief Scientific OfficerSSale−30.0K$20.28−$608.3K−3.2%899.4K after2 lots
Oct 7, 2021 (view filing)Oct 52 daysLieu Hsiao DSVP, Chief Medical OfficerSSale−2.00K$22.00−$44.0K−100.0%0 after
Sep 14, 2021 (view filing)Sep 13-141 dayChen Jin-LongChief Scientific OfficerSSale−30.0K$25.84−$775.3K−3.1%929.4K after5 lots
Aug 13, 2021 (view filing)Aug 11-122 daysLieu Hsiao DSVP, Chief Medical OfficerSSale−10.3K$23.39−$239.9K−100.0%0 after2 lots
Aug 11, 2021 (view filing)Aug 9-102 daysChen Jin-LongChief Scientific OfficerSSale−30.0K$23.81−$714.2K−3.0%959.4K after4 lots